Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
UROY's earnings releases have historically occurred during varying times, making Day 0 moves reflect either anticipation or immediate reaction depending on the specific release timing.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-03-10 | +$0.13 (+3.52%) | $0.23 (6.37%) | -$0.01 (-0.26%) | $0.27 (7.07%) |
| 2025-12-11 | +$0.18 (+4.88%) | $0.27 (7.32%) | -$0.22 (-5.68%) | $0.34 (8.79%) |
| 2025-09-11 | -$0.06 (-1.83%) | $0.08 (2.44%) | -$0.08 (-2.48%) | $0.21 (6.52%) |
| 2025-07-16 | +$0.09 (+3.64%) | $0.13 (5.06%) | +$0.06 (+2.34%) | $0.25 (9.77%) |
| 2025-03-06 | -$0.04 (-2.21%) | $0.08 (4.42%) | -$0.04 (-2.26%) | $0.07 (3.95%) |
| 2024-09-12 | +$0.04 (+1.81%) | $0.10 (4.52%) | -$0.13 (-5.78%) | $0.17 (7.56%) |
| 2024-07-24 | -$0.08 (-3.38%) | $0.10 (4.22%) | -$0.04 (-1.75%) | $0.10 (4.37%) |
| 2024-03-15 | N/A | N/A | N/A | N/A |
| Avg Abs Move | 3.04% | 4.91% | 2.94% | 6.86% |
Historical price action shows moderate volatility around earnings, with an average absolute Day 0 move of 3.04% and Day +1 move of 2.94%. The stock has moved in both directions, with no clear pattern of consistent post-earnings gains or losses. The most significant reactions came in December 2025 (4.88% Day 0 gain followed by 5.68% Day 1 decline) and March 2026 (3.52% Day 0 gain). Trading ranges have been wider on Day +1 (6.86% average) compared to Day 0 (4.91% average), suggesting initial reactions often get reassessed as investors digest the details. Given the stock's small absolute price and the binary nature of royalty income recognition, investors should expect meaningful percentage swings regardless of whether results beat or miss.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 31) |
| Expected Move | $0.43 (14.60%) |
| Expected Range | $2.49 to $3.34 |
| Implied Volatility | 81.13% |
The options market is pricing a 14.60% expected move through the August expiration, significantly higher than the historical average Day 0 move of 3.04% and even exceeding the Day +1 average of 2.94%. This elevated implied volatility of 81.13% suggests options traders are anticipating a larger-than-typical reaction, possibly reflecting uncertainty around production updates from key royalty assets or broader uranium market developments that could materially impact UROY's outlook.
Analysts maintain a bullish stance on UROY with an average rating of 4.50 (between Buy and Strong Buy) and a mean price target of $4.82, implying 66% upside from the current price of $2.90. The consensus includes 2 Strong Buy and 2 Moderate Buy ratings with no Hold or Sell recommendations among the 4 analysts covering the stock.
Sentiment has improved over the past month, with the average rating strengthening from 4.00 to 4.50 as one analyst upgraded from Hold to Strong Buy. This shift reflects growing confidence in the uranium market recovery and UROY's positioning to benefit. The price target range spans from $4.06 to $5.90, with even the low-end estimate suggesting substantial upside potential.
The bullish analyst consensus stands in stark contrast to the stock's recent price weakness, suggesting analysts believe current levels present an attractive entry point ahead of what they expect will be improving fundamentals as uranium prices remain elevated and royalty cash flows accelerate.
UROY enters earnings with deteriorating technical momentum, as the Barchart Technical Opinion shows an 88% Sell signal, slightly improved from 100% Sell readings both last week and last month. The stock is trading at $2.90, positioned above its short-term moving averages but below all longer-term trend indicators.
Timeframe Analysis:
Trend Characteristics: The combination of Average strength and Average direction suggests UROY is experiencing a typical downtrend without extreme momentum in either direction, creating a neutral technical environment heading into the catalyst.
The stock trades above its 5-day ($2.77), 10-day ($2.73), and 20-day ($2.76) moving averages, indicating some recent stabilization, but remains below the critical 50-day ($3.17), 100-day ($3.45), and 200-day ($3.76) moving averages. This configuration shows the stock is 23% below its 200-day moving average, confirming the longer-term downtrend remains intact despite short-term steadying.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $2.77 | 50-Day MA | $3.17 |
| 10-Day MA | $2.73 | 100-Day MA | $3.45 |
| 20-Day MA | $2.76 | 200-Day MA | $3.76 |
The key technical level to watch is the 50-day moving average at $3.17, which has acted as resistance and represents a 9% move from current levels. A strong earnings beat could propel the stock back above this threshold and potentially shift the medium-term trend. Conversely, failure to hold above the 20-day moving average at $2.76 on any disappointment would likely accelerate the existing downtrend. The technical setup is cautionary heading into earnings—while short-term stabilization provides a base, the weight of evidence from longer-term indicators suggests the path of least resistance remains lower absent a significant positive catalyst from the results.